ஹிசாமிட்சு மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹிசாமிட்சு மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹிசாமிட்சு மருந்துகள் Today - Breaking & Trending Today

Topical Drug Delivery Market Competitive Landscape Forecasts to 2028: Global Industry Growth, Share, Size, Trends – KSU


emergenApril 20, 2021
The rising prevalence of skin diseases such as acne, eczema, psoriasis, etc. continues to fuel growth of the global topical drug delivery market. Some other crucial factors such as this route of drug administration being non-invasive in nature, improved efficiency of drugs administered into the skin, and increasing global geriatric population are other major factors further driving growth of the topical drug delivery market. Moreover, new topical drug approvals and rapid technological advancement and developments, and constant innovations in the field are likely to propel growth of the topical drug delivery market to a significant extent over the forecast period. ....

United States , Saudi Arabia , South Korea , Asia Pacific , Bayer Ag , Encore Dermatology Inc , Merck Co , Glenmark Pharmaceuticals , Hisamitsu Pharmaceuticals , Research Scope , Burn Center , Bausch Health Companies , Emergen Research , Research Sources , Topical Drug Delivery , Topical Drug Delivery Market , Encore Dermatology , Form Outlook , Kilo Tons , Use Outlook , ஒன்றுபட்டது மாநிலங்களில் , சவுதி அரேபியா , தெற்கு கொரியா , ஆசியா பெஸிஃபிக் , அர்ந்‌கோர் தோல் நோய் இன்க் , மெர்க் இணை ,

Hisamitsu America, Marketers of the Salonpas Line of Pain-Relieving Products, Announce Launch of Salonpas(R) Arthritis Pain Relief Gel


(1)
FLORHAM PARK, NJ
/ ACCESSWIRE / March 1, 2021 / Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the manufacturers of the Salonpas
® line of pain-relieving products, announce the availability of the Salonpas® Arthritis Pain Relief Gel, which features the most prescribed topical pain medicine clinically proven to relieve arthritis pain in major joints. That medicine is prescription-strength diclofenac, which was approved by the FDA for over-the-counter (OTC) use in 2020.
Salonpas
® has a long history of driving growth through our scientific approach to pain relief which includes providing the first FDA-approved OTC topical pain reliever to the public in 2008, said John Incledon, President & CEO, Hisamitsu America. Our science-based approach is critical to our support of the ....

United States , Nancy Thompson , John Incledon , Hisamitsu America , Hisamitsu Pharmaceutical Co Inc , Hisamitsu Pharmaceuticals , Vorticom Inc , Arthritis Pain Relief Gel , ஒன்றுபட்டது மாநிலங்களில் , நான்சி தாம்சன் , ஹிசாமிட்சு அமெரிக்கா , ஹிசாமிட்சு மருந்து இணை இன்க் , ஹிசாமிட்சு மருந்துகள் , கீல்வாதம் வலி துயர் நீக்கம் கேள் , துயர் நீக்கம் ,